ACACB
Acetyl-CoA carboxylase 2
Also known as: ACACB_HUMAN, ACACbeta, ACC-beta, ACC2, ACCB, ACCbeta, HACC275
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O00763
- Gene
- ACACB
- Ensembl
- ENSG00000076555
- Chromosome
- 12
- Canonical length
- 2458 aa
- Protein class
- Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
- Secretome location
- Intracellular and membrane
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
Acetyl-CoA carboxylase (ACC) is a complex multifunctional enzyme system. ACC is a biotin-containing enzyme which catalyzes the carboxylation of acetyl-CoA to malonyl-CoA, the rate-limiting step in fatty acid synthesis. ACC-beta is thought to control fatty acid oxidation by means of the ability of malonyl-CoA to inhibit carnitine-palmitoyl-CoA transferase I, the rate-limiting step in fatty acid uptake and oxidation by mitochondria. ACC-beta may be involved in the regulation of fatty acid oxidation, rather than fatty acid biosynthesis. [provided by RefSeq, Oct 2022]
Canonical amino-acid sequenceUniProt
2458 residues, UniProt reviewed canonical sequence.
>O00763|ACACB
1 MVLLLCLSCL IFSCLTFSWL KIWGKMTDSK PITKSKSEAN LIPSQEPFPA SDNSGETPQR
61 NGEGHTLPKT PSQAEPASHK GPKDAGRRRN SLPPSHQKPP RNPLSSSDAA PSPELQANGT
121 GTQGLEATDT NGLSSSARPQ GQQAGSPSKE DKKQANIKRQ LMTNFILGSF DDYSSDEDSV
181 AGSSRESTRK GSRASLGALS LEAYLTTGEA ETRVPTMRPS MSGLHLVKRG REHKKLDLHR
241 DFTVASPAEF VTRFGGDRVI EKVLIANNGI AAVKCMRSIR RWAYEMFRNE RAIRFVVMVT
301 PEDLKANAEY IKMADHYVPV PGGPNNNNYA NVELIVDIAK RIPVQAVWAG WGHASENPKL
361 PELLCKNGVA FLGPPSEAMW ALGDKIASTV VAQTLQVPTL PWSGSGLTVE WTEDDLQQGK
421 RISVPEDVYD KGCVKDVDEG LEAAERIGFP LMIKASEGGG GKGIRKAESA EDFPILFRQV
481 QSEIPGSPIF LMKLAQHARH LEVQILADQY GNAVSLFGRD CSIQRRHQKI VEEAPATIAP
541 LAIFEFMEQC AIRLAKTVGY VSAGTVEYLY SQDGSFHFLE LNPRLQVEHP CTEMIADVNL
601 PAAQLQIAMG VPLHRLKDIR LLYGESPWGV TPISFETPSN PPLARGHVIA ARITSENPDE
661 GFKPSSGTVQ ELNFRSSKNV WGYFSVAATG GLHEFADSQF GHCFSWGENR EEAISNMVVA
721 LKELSIRGDF RTTVEYLINL LETESFQNND IDTGWLDYLI AEKVQAEKPD IMLGVVCGAL
781 NVADAMFRTC MTDFLHSLER GQVLPADSLL NLVDVELIYG GVKYILKVAR QSLTMFVLIM
841 NGCHIEIDAH RLNDGGLLLS YNGNSYTTYM KEEVDSYRIT IGNKTCVFEK ENDPTVLRSP
901 SAGKLTQYTV EDGGHVEAGS SYAEMEVMKM IMTLNVQERG RVKYIKRPGA VLEAGCVVAR
961 LELDDPSKVH PAEPFTGELP AQQTLPILGE KLHQVFHSVL ENLTNVMSGF CLPEPVFSIK
1021 LKEWVQKLMM TLRHPSLPLL ELQEIMTSVA GRIPAPVEKS VRRVMAQYAS NITSVLCQFP
1081 SQQIATILDC HAATLQRKAD REVFFINTQS IVQLVQRYRS GIRGYMKTVV LDLLRRYLRV
1141 EHHFQQAHYD KCVINLREQF KPDMSQVLDC IFSHAQVAKK NQLVIMLIDE LCGPDPSLSD
1201 ELISILNELT QLSKSEHCKV ALRARQILIA SHLPSYELRH NQVESIFLSA IDMYGHQFCP
1261 ENLKKLILSE TTIFDVLPTF FYHANKVVCM ASLEVYVRRG YIAYELNSLQ HRQLPDGTCV
1321 VEFQFMLPSS HPNRMTVPIS ITNPDLLRHS TELFMDSGFS PLCQRMGAMV AFRRFEDFTR
1381 NFDEVISCFA NVPKDTPLFS EARTSLYSED DCKSLREEPI HILNVSIQCA DHLEDEALVP
1441 ILRTFVQSKK NILVDYGLRR ITFLIAQEKE FPKFFTFRAR DEFAEDRIYR HLEPALAFQL
1501 ELNRMRNFDL TAVPCANHKM HLYLGAAKVK EGVEVTDHRF FIRAIIRHSD LITKEASFEY
1561 LQNEGERLLL EAMDELEVAF NNTSVRTDCN HIFLNFVPTV IMDPFKIEES VRYMVMRYGS
1621 RLWKLRVLQA EVKINIRQTT TGSAVPIRLF ITNESGYYLD ISLYKEVTDS RSGNIMFHSF
1681 GNKQGPQHGM LINTPYVTKD LLQAKRFQAQ TLGTTYIYDF PEMFRQALFK LWGSPDKYPK
1741 DILTYTELVL DSQGQLVEMN RLPGGNEVGM VAFKMRFKTQ EYPEGRDVIV IGNDITFRIG
1801 SFGPGEDLLY LRASEMARAE GIPKIYVAAN SGARIGMAEE IKHMFHVAWV DPEDPHKGFK
1861 YLYLTPQDYT RISSLNSVHC KHIEEGGESR YMITDIIGKD DGLGVENLRG SGMIAGESSL
1921 AYEEIVTISL VTCRAIGIGA YLVRLGQRVI QVENSHIILT GASALNKVLG REVYTSNNQL
1981 GGVQIMHYNG VSHITVPDDF EGVYTILEWL SYMPKDNHSP VPIITPTDPI DREIEFLPSR
2041 APYDPRWMLA GRPHPTLKGT WQSGFFDHGS FKEIMAPWAQ TVVTGRARLG GIPVGVIAVE
2101 TRTVEVAVPA DPANLDSEAK IIQQAGQVWF PDSAYKTAQA VKDFNREKLP LMIFANWRGF
2161 SGGMKDMYDQ VLKFGAYIVD GLRQYKQPIL IYIPPYAELR GGSWVVIDAT INPLCIEMYA
2221 DKESRGGVLE PEGTVEIKFR KKDLIKSMRR IDPAYKKLME QLGEPDLSDK DRKDLEGRLK
2281 AREDLLLPIY HQVAVQFADF HDTPGRMLEK GVISDILEWK TARTFLYWRL RRLLLEDQVK
2341 QEILQASGEL SHVHIQSMLR RWFVETEGAV KAYLWDNNQV VVQWLEQHWQ AGDGPRSTIR
2401 ENITYLKHDS VLKTIRGLVE ENPEVAVDCV IYLSQHISPA ERAQVVHLLS TMDSPASTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ACACB can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 172 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 172 nTPM
- skeletal muscle: 160 nTPM
- breast: 98 nTPM
- tongue: 57 nTPM
- liver: 52 nTPM
- colon: 35 nTPM
Single-cell type
- adipocytes: 3,716 nCPM
- breast lactating cells: 983 nCPM
- myonuclei: 659 nCPM
- cardiomyocytes: 606 nCPM
- distal convoluted tubule cells: 424 nCPM
- loop of henle epithelial cells: 391 nCPM
Immune cell
- eosinophil: 18 nTPM
- basophil: 4.7 nTPM
- naive B-cell: 3.1 nTPM
- memory B-cell: 2.2 nTPM
- naive CD4 T-cell: 1.8 nTPM
- gdT-cell: 1.1 nTPM
Brain region
- choroid plexus: 72 nTPM
- basal ganglia: 61 nTPM
- midbrain: 57 nTPM
- amygdala: 57 nTPM
- thalamus: 57 nTPM
- medulla oblongata: 42 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ACACB.
Disease | ImmuneIEDB
Conditions an epitope on ACACB was assayed in.
- skin melanoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.86
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.57
- DepMap mean gene effect
- -0.11
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- acetyl-CoA metabolic process
- D-glucose import
- energy homeostasis
- fatty acid biosynthetic process
- fatty acid homeostasis
- fatty acid oxidation
- intracellular glutamate homeostasis
- malonyl-CoA biosynthetic process
- negative regulation of fatty acid beta-oxidation
- pentose-phosphate shunt
- positive regulation of heart growth
- positive regulation of lipid storage
- protein homotetramerization
- regulation of cardiac muscle hypertrophy in response to stress
- regulation of glucose metabolic process
- response to caloric restriction
- response to nutrient
- response to xenobiotic stimulus
- tricarboxylic acid metabolic process
- intracellular aspartate homeostasis
- lactic acid secretion
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Biotin/lipoyl attachment
- Carbamoyl phosphate synthase, ATP-binding domain
- Biotin carboxylase-like, N-terminal domain
- Biotin carboxylase, C-terminal
- Single hybrid motif
- Rudiment single hybrid motif
- ATP-grasp fold
- Acetyl-coenzyme A carboxyltransferase, N-terminal
- Acetyl-coenzyme A carboxyltransferase, C-terminal
- Biotin carboxylation domain
- Acetyl-CoA carboxylase, central domain
- ATP-grasp fold, subdomain 1
- Pre-ATP-grasp domain superfamily
- ClpP/crotonase-like domain superfamily
- Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta
- Acetyl-CoA carboxylase, BT domain
- Acetyl-CoA carboxylase
- Biotin carboxylase, N-terminal domain
- Biotin-requiring enzyme
- Carboxyl transferase domain
- Biotin carboxylase C-terminal domain
- Carbamoyl-phosphate synthase L chain, ATP binding domain
- Acetyl-CoA carboxylase, central region
- Acetyl-CoA carboxylase, BT domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ACACB in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ACACB as an antibody target. Whether an autoantibody or antibody against ACACB could matter depends on whether native ACACB is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ACACB is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ACACB as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...